Clinical Trial: Association between Baseline Hematological Markers and Survival Outcomes in Patients with Newly Diagnosed Lung Cancer and Esophageal Cancer: A Retrospective Cohort Study (China)

Posted On: 2026-09-21

China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Association between Baseline Hematological Markers and Survival Outcomes in Patients with Newly Diagnosed Lung Cancer and Esophageal Cancer: A Retrospective Cohort Study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132994

Registration Time: 2026/09/20

Type: Observational study

Primary Sponsor: Xintai People’s Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=344353

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Association between Baseline Hematological Markers and Survival Outcomes in Patients with Newly Diagnosed Lung Cancer and Esophageal Cancer: A Retrospective Cohort Study (China)